Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

4.0K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Botanical Origin-Dependent Phytochemical Profiles and Pharmaceutical Properties of Medical-Grade Honeys: Transdermal Delivery and Antibacterial Efficacy in a Wound Fluid Model.

Molecules (Basel, Switzerland)·2026
Same author

Congenital long QT syndrome in the pregnant women: a systematic review.

Ginekologia polska·2026
Same author

Content of Fatty Acid and Eicosanoids in Muscle and Intestinal Tissue of C57BL/6 Mice Subjected to Long-Term Caloric Restriction.

Nutrients·2026
Same author

Neuroprotective Potential of <i>Hericium erinaceus</i> Through Modulation of Inflammatory Signaling in THP-1 Macrophages Under Low-Level Lead Exposure.

International journal of molecular sciences·2026
Same author

Evaluation of Intra-Amniotic Infection Detection Based on Available Diagnostic Methods.

Medicina (Kaunas, Lithuania)·2025
Same author

Distribution of High-Risk HPV in Cervical Versus Oropharyngeal Samples: Results from a Prospective Screening Study in a Cohort of European Women of Reproductive Age.

Pathogens (Basel, Switzerland)·2025

Related Experiment Video

Updated: Jun 3, 2025

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

6.6K

Evaluation of BRIP-1 (FANCJ) and FANCI Protein Expression in Ovarian Cancer Tissue.

Mateusz Kozłowski1, Dominika Borzyszkowska1, Anna Golara1

  • 1Department of Reconstructive Surgery and Gynecological Oncology, Pomeranian Medical University in Szczecin, Al. Powstańców Wielkopolskich 72, 70-111 Szczecin, Poland.

Biomedicines
|January 8, 2025
PubMed
Summary

FANCI and BRIP-1 (FANCJ) protein expression in ovarian cancer tissues may help differentiate clinical features. Lower FANCI expression is linked to lower FIGO stage ovarian cancer.

Keywords:
BRIP-1FANCIFANCJHGSOCexpressionmarkerovarian cancer

More Related Videos

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer
04:20

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer

Published on: February 9, 2024

869
Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity
09:00

Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity

Published on: December 31, 2015

26.6K

Related Experiment Videos

Last Updated: Jun 3, 2025

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

6.6K
Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer
04:20

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer

Published on: February 9, 2024

869
Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity
09:00

Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity

Published on: December 31, 2015

26.6K

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Ovarian cancer remains a significant health concern for women globally.
  • Identifying reliable biomarkers for ovarian cancer is crucial for improved patient outcomes.
  • Current research seeks novel markers to aid in diagnosis and prognosis.

Purpose of the Study:

  • To investigate the expression levels of BRIP-1 (also known as FANCJ) and FANCI proteins in ovarian cancer tissues.
  • To determine the correlation between the expression of these proteins and various clinical features of ovarian cancer.
  • To assess the potential of FANCI and BRIP-1 as diagnostic or prognostic markers.

Main Methods:

  • The study included 68 patients diagnosed with ovarian cancer.
  • Immunohistochemical techniques were employed to evaluate FANCI and BRIP-1 protein expression in tumor samples.
  • Patients were categorized into high-grade serous ovarian cancer (HGSOC) and non-HGSOC groups for comparative analysis.

Main Results:

  • FANCI protein predominantly exhibited moderate to strong positive expression.
  • BRIP-1 (FANCJ) protein mostly showed no or positive expression.
  • Lower expression levels of both FANCI and BRIP-1 were associated with differences in clinical stage for HGSOC, and lower BRIP-1 expression correlated with menopausal status.

Conclusions:

  • FANCI protein expression serves as a potential marker associated with lower FIGO stage and high-grade histology in ovarian cancers.
  • The findings suggest that FANCI and BRIP-1 protein expression patterns may offer insights into ovarian cancer characteristics.
  • Further research is warranted to fully elucidate the clinical utility of these proteins in ovarian cancer management.